Immunopeptidomics reveals determinants of Mycobacterium tuberculosis antigen presentation on MHC class I
eLife · 19.04.2023 · 12
DOI: 10.7554/elife.84070 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, online erschienen am 19.04.2023. Verfasst von Owen Leddy und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, United States. Hauptthemen laut MEDLINE: Antigen Presentation, Mycobacterium tuberculosis. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIEHS NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
CD8+ T cell recognition of Mycobacterium tuberculosis ( Mtb )-specific peptides presented on major histocompatibility complex class I (MHC-I) contributes to immunity to tuberculosis (TB), but the principles that govern presentation of Mtb antigens on MHC-I are incompletely understood. In this study, mass spectrometry (MS) analysis of the MHC-I repertoire of Mtb -infected primary human macrophages reveals that substrates of Mtb ’s type VII secretion systems (T7SS) are overrepresented among Mtb -derived peptides presented on MHC-I. Quantitative, targeted MS shows that ESX-1 activity is required for presentation of Mtb peptides derived from both ESX-1 substrates and ESX-5 substrates on MHC-I, consistent with a model in which proteins secreted by multiple T7SSs access a cytosolic antigen processing pathway via ESX-1-mediated phagosome permeabilization. Chemical inhibition of proteasome activity, lysosomal acidification, or cysteine cathepsin activity did not block presentation of Mtb antigens on MHC-I, suggesting involvement of other proteolytic pathways or redundancy among multiple pathways. Our study identifies Mtb antigens presented on MHC-I that could serve as targets for TB vaccines, and reveals how the activity of multiple T7SSs interacts to contribute to presentation of Mtb antigens on MHC-I.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, United States.
- Ragon Institute of Massachusetts General Hospital, Harvard, and MIT, Cambridge, United States.
- Koch Institute for Integrative Cancer Research, Cambridge, United States.
- Center for Precision Cancer Medicine, Cambridge, United States.
ORCID-Profile: Owen Leddy, Forest M White, Bryan D Bryson
Förderung
- NIGMS NIH HHS
- NIEHS NIH HHS
- NIAID NIH HHS
- National Institutes of Health
- National Institute of Environmental Health Sciences
- Center for Precision Cancer Medicine
Zitieren
APA
Leddy, O., White, F. M., & Bryson, B. D. (2023). Immunopeptidomics reveals determinants of Mycobacterium tuberculosis antigen presentation on MHC class I. eLife, 12. https://doi.org/10.7554/elife.84070
Vancouver
Leddy O, White FM, Bryson BD. Immunopeptidomics reveals determinants of Mycobacterium tuberculosis antigen presentation on MHC class I. eLife. 2023;12. doi:10.7554/elife.84070
BibTeX
@article{Leddy2023,
author = {Leddy, Owen and White, Forest M and Bryson, Bryan D},
title = {Immunopeptidomics reveals determinants of Mycobacterium tuberculosis antigen presentation on MHC class I},
journal = {eLife},
year = {2023},
volume = {12},
doi = {10.7554/elife.84070}
}
EUVIMED